Key result
Type 1 diabetes in premenopausal women was associated with significantly lower insulin sensitivity compared to nondiabetic controls (49.3 vs. 73.2 micromol/min x kg fat free mass, P=0.01).
Why the study?
Does type 1 diabetes mellitus affect insulin sensitivity, abdominal fat, androgens, lipids, and blood pressure in premenopausal women compared to nondiabetic controls?
Case-Control (n=20)
Does type 1 diabetes mellitus affect insulin sensitivity, abdominal fat, androgens, lipids, and blood pressure in premenopausal women compared to nondiabetic controls?
Premenopausal women with type 1 diabetes exhibit greater insulin resistance compared to BMI-matched controls, which is unrelated to abdominal adiposity, lipids, or androgens.
T1D-linked insulin resistance in premenopausal women may warrant closer CV monitoring; leaves open prospective confirmation independent of adiposity.
The increased cardiovascular risk in type 1 diabetes may be related, at least in part, to insulin resistance. The aim of this study was to assess the relationships between insulin sensitivity, abdominal fat, androgens, lipids, and blood pressure in 10 premenopausal women with type 1 diabetes (mean +/- SD, hemoglobin A1c 8.1 +/- 1.0%) and 10 nondiabetic body mass index-matched controls. Insulin sensitivity (glucose infusion rate during euglycemic-hyperinsulinemic clamp) was significantly less in the type 1 diabetes group than in controls (49.3 +/- 14.8 vs. 73.2 +/- 21.6 micromol/min x kg fat free mass, respectively, P = 0.01). The two groups were similar with respect to lipids, androgens, energy expenditure, physical activity, blood pressure, and abdominal adiposity (intra-abdominal fat by four-slice computed tomography and central abdominal fat by dual-energy x-ray absorptiometry). There were no relationships between glucose infusion rate, abdominal adiposity, and androgen levels in subjects with type 1 diabetes, in contrast to controls. Our results demonstrate greater insulin resistance in a group of premenopausal women with type 1 diabetes compared with nondiabetic controls, unrelated to abdominal adiposity, lipids, or androgens.
No takes yet. Share an insight, caveat, or question.
Greenfield et al. (2002) conducted a case-control in Type 1 Diabetes Mellitus (n=20). Type 1 diabetes vs. Nondiabetic BMI-matched controls was evaluated on Insulin sensitivity (glucose infusion rate during euglycemic-hyperinsulinemic clamp) (p=0.01). Type 1 diabetes in premenopausal women was associated with significantly lower insulin sensitivity compared to nondiabetic controls (49.3 vs. 73.2 micromol/min x kg fat free mass, P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Women and heart diseaseMore from The Journal of Clinical Endocrinology & Metabolism